Robbins, Mark

Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial

Azizi, M., Schmieder, R. E., Mahfoud, F., Weber, M. A., Daemen, J., Davies, J., Basile, J., Kirtane, A. J., Wang, Y., Lobo, M. D., et al. (2018) · The Lancet

Blood Pressure and Hypertension StudiesRenal and Vascular Pathologies

Cited by 740

Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial

Azizi, M., Sanghvi, K., Saxena, M., Gosse, P., Reilly, J. P., Levy, T., Rump, L. C., Persu, A., Basile, J., Bloch, M. J., et al. (2021) · The Lancet

Blood Pressure and Hypertension StudiesRenal and Vascular Pathologies

Cited by 439

Racial Differences in the Prevalence of Severe Aortic Stenosis

Patel, D. K., Green, K. D., Fudim, M., Harrell, F. E., Wang, T. J., & Robbins, M. A. (2014) · Journal of the American Heart Association

Cardiac Valve Diseases and TreatmentsAortic Disease and Treatment Approaches

Cited by 127

Impact of Renal Denervation on Patients With Obstructive Sleep Apnea and Resistant Hypertension – Insights From the SYMPLICITY HTN-3 Trial –

Kario, K., Bhatt, D. L., Kandzari, D. E., Brar, S., Flack, J. M., Gilbert, C., Oparil, S., Robbins, M., Townsend, R. R., & Bakris, G. (2016) · Circulation Journal

Blood Pressure and Hypertension StudiesObstructive Sleep Apnea Research

Cited by 84